| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |